Utility of Measuring (1,3)-β-D-Glucan in Cerebrospinal Fluid for Diagnosis of Fungal Central Nervous System Infection

被引：42
|
作者：
Lyons, Jennifer L. [1 ,2 ]
Thakur, Kiran T. [3 ]
Lee, Rick [4 ]
Watkins, Tonya [5 ]
Pardo, Carlos A. [3 ]
Carson, Kathryn A. [6 ]
Markley, Barbara [7 ]
Finkelman, Malcolm A. [7 ]
Marr, Kieren A. [8 ,9 ]
Roos, Karen L. [10 ]
Zhang, Sean X. [4 ,5 ]
机构：
[1] Brigham & Womens Hosp, Dept Neurol, Div Neurol Infect, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA
[4] Johns Hopkins Univ Hosp, Microbiol Lab, Baltimore, MD 21287 USA
[5] Johns Hopkins Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[7] Associates Cape Cod Inc, Falmouth, MA USA
[8] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA
[9] Johns Hopkins Sch Med, Dept Oncol, Div Infect Dis, Baltimore, MD USA
[10] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2015年 / 53卷 / 01期
基金：
美国国家卫生研究院;
关键词：
BETA-D-GLUCAN; MULTISTATE OUTBREAK; PLASMA; ASSAY; (1-3)-BETA-D-GLUCAN; MENINGITIS; AID;
D O I：
10.1128/JCM.02301-14
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
(1-3)-beta-D-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.
引用
收藏
页码：319 / 322
页数：4
相关论文
共 50 条
  • [41] Prognostic value of serial (1,3)-β-D-glucan measurements in ICU patients with invasive candidiasis
    Carelli, Simone
    Posteraro, Brunella
    Torelli, Riccardo
    De Carolis, Elena
    Vallecoccia, Maria Sole
    Xhemalaj, Rikardo
    Cutuli, Salvatore Lucio
    Tanzarella, Eloisa Sofia
    Dell'Anna, Antonio Maria
    Lombardi, Gianmarco
    Cammarota, Fabiola
    Caroli, Alessandro
    Grieco, Domenico Luca
    Sanguinetti, Maurizio
    Antonelli, Massimo
    De Pascale, Gennaro
    CRITICAL CARE, 2024, 28 (01)
  • [42] (1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality
    Esteves, Patricia
    Lopes Lima, Soraia
    Salles de Azevedo Melo, Analy
    Maria Beirao, Elisa
    Nucci, Marcio
    Colombo, Arnaldo L.
    MYCOSES, 2021, 64 (03) : 264 - 271
  • [43] Simultaneous increase in 1,3-β-D-glucan and procalcitonin levels in Pseudomonas aeruginosa infection
    Koya, Junji
    Nannya, Yasuhito
    Kobayashi, Hisayuki
    Okugawa, Shu
    Moriya, Kyoji
    Kurokawa, Mineo
    JOURNAL OF INFECTION, 2013, 67 (02) : 164 - 166
  • [44] Clinical Evaluation of a (1,3)-β-D-Glucan Assay for Presumptive Diagnosis of Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
    Del Bono, Valerio
    Mularoni, Alessandra
    Furfaro, Elisa
    Delfino, Emanuele
    Rosasco, Lorenzo
    Miletich, Franca
    Viscoli, Claudio
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (10) : 1524 - 1526
  • [45] Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis
    Li, Fengtian
    Yu, Xiaotian
    Ye, Liyan
    Zhou, Guang
    Wang, Leili
    Luo, Yanping
    MEDICAL MYCOLOGY, 2019, 57 (08) : 976 - 986
  • [46] Cerebrospinal fluid analysis in emergency patients with suspected infection of the central nervous system
    Voelk, Stefanie
    Dobler, Fabian
    Koedel, Uwe
    Pfister, Hans-Walter
    Bruegel, Mathias
    Schubert, Soeren
    Klein, Matthias
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (03) : 702 - 709
  • [47] Serum (1→3)-β-D-Glucan Levels in Primary Infection and Pulmonary Colonization with Pneumocystis jirovecii
    Damiani, Celine
    Le Gal, Solene
    Lejeune, Delphine
    Brahimi, Naima
    Virmaux, Michele
    Nevez, Gilles
    Totet, Anne
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (05) : 2000 - 2002
  • [48] Detection of (1,3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts
    Theel, Elitza S.
    Jespersen, Deborah J.
    Iqbal, Seher
    Bestrom, Jean E.
    Rollins, Leonard O.
    Misner, Lori J.
    Markley, Barbara J.
    Mandrekar, Jayawant
    Baddour, Larry M.
    Limper, Andrew H.
    Wengenack, Nancy L.
    Binnicker, Matthew J.
    MYCOPATHOLOGIA, 2013, 175 (1-2) : 33 - 41
  • [49] The Clinical Significance of Serum 1,3-β-D-Glucan For the Diagnosis of Candidemia in Severe Burn Patients
    Kaita, Yasuhiko
    Tarui, Takehiko
    Otsu, Akiyasu
    Tanaka, Yuya
    Suzuki, Jun
    Yoshikawa, Kei
    Yamaguchi, Yoshihiro
    JOURNAL OF BURN CARE & RESEARCH, 2019, 40 (01) : 104 - 106
  • [50] Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis
    O'Regan, Siobhan
    O'Kelly, Brendan
    Reidy, Paul
    O'Toole, Aoibhlinn
    Caird, John
    McNally, Cora
    McConkey, Samuel
    de Barra, Eoghan
    JOURNAL OF FUNGI, 2022, 8 (06)
12345